C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2011
10/26/2011	EP2379526A2 Tetrazole substituted anthranilic acid amides as pesticides
10/26/2011	EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011	EP2379520A2 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
10/26/2011	EP2181985B1 Antiviral Agent
10/26/2011	EP2142538B1 Derivatives and analogs of chroman as functionally selective alpha2c adrenoreceptor agonists
10/26/2011	EP2057141B1 Pyrimidone compounds as gsk-3 inhibitors
10/26/2011	EP2037739B1 Benzyl-substituted quinolone m1 receptor positive allosteric modulators
10/26/2011	EP2001848B1 Piperidines and related compounds for the treatment of dementia
10/26/2011	EP1846394B1 Pyrazolylaminopyridine derivatives useful as kinase inhibitors
10/26/2011	EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011	EP1425010B1 Substituted indoles and their use as integrin antagonists
10/26/2011	CN1980934B Novel indole derivatives as selective androgen receptor modulators (sarms)
10/26/2011	CN102227420A Quinazolinone, quinolone and related analogs as sirtuin modulators
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227407A Hepatitis c virus inhibitors
10/26/2011	CN102225936A Processes for producing compound
10/26/2011	CN102225935A Manufacturing method of proPiconazole
10/26/2011	CN102225927A Amide fragment-containing (Z)-type nitenpyram compound and preparation method and application thereof
10/26/2011	CN102225926A Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
10/26/2011	CN101070304B Quinoline derivatives and their use as mycrobacterial inhibitors
10/25/2011	US8044209 Pyrrolydine derivatives as IAP inhibitors
10/25/2011	US8044207 Pyridinoylpiperidines as 5-HT1F agonists
10/25/2011	US8044103 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
10/25/2011	US8044097 Chroman derivatives
10/25/2011	US8044090 N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
10/25/2011	US8044073 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
10/20/2011	WO2011130515A1 Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein production
10/20/2011	WO2011130419A2 Broad spectrum antiviral and antiparasitic agents
10/20/2011	WO2011128381A1 Triazole compounds as ksp inhibitors
10/20/2011	WO2011128251A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	US20110257409 Ionic Liquid Epoxy Resin Monomers
10/20/2011	US20110257399 Fluorescent calcium indicators that are ratiometric and emit in the red spectrum
10/20/2011	US20110257379 Lead compound of anti-hypertensive drug and method for screening the same
10/20/2011	US20110257221 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257199 Novel teraryl compounds as antiparasitic agents
10/20/2011	US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
10/20/2011	US20110257174 Chromenone analogs as sirtuin modulators
10/20/2011	US20110257169 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
10/20/2011	US20110257164 Dipeptidyl peptidase iv inhibitors
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256067 Contrast agents endowed with high relaxivity
10/20/2011	CA2795387A1 Novel 3,3-dimethyl tetrahydroquinoline derivatives
10/20/2011	CA2794406A1 Triazole compounds as ksp inhibitors
10/19/2011	EP2377854A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors
10/19/2011	EP2377851A1 Isoquinoline derivative
10/19/2011	EP2377845A1 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof
10/19/2011	EP2376481A1 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
10/19/2011	EP2376480A2 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
10/19/2011	EP2376479A1 Substituted furancarboxamides, and use thereof
10/19/2011	EP2376083A1 Quinazoline inhibitors of bace 1 and methods of using
10/19/2011	EP2170857B1 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same
10/19/2011	EP2004607B1 (4-(4-[6-(trifluoromethyl-pyridin-3-ylamino)-N-containing-heteroaryl]-phenyl)-cyclohexyl)-acetic acid derivatives and pharmaceutical uses thereof
10/19/2011	EP1923387B1 Acylguanidine derivative or salt thereof
10/19/2011	EP1694651B1 Herbicidal pyrimidines
10/19/2011	EP1648870B1 Sulfonic acid derivatives of polycyclic dyes used for analytical applications
10/19/2011	EP1494671B1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists
10/19/2011	EP1482931B1 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
10/19/2011	CN1993357B Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
10/19/2011	CN1251097B Phthalazines with angiogenesis inhibiting activity
10/19/2011	CN102224150A Aromatic amine derivative, and organic electroluminescent element
10/19/2011	CN102224143A 1h-benz imidazole-5-carboxamides as anti-inflammatory agents
10/19/2011	CN102219780A Method for preparing (3R, 5S, E)-7-{2-(N-methylsulphonylamino) -4-(4-fluorophenyl)-6-isopropyl-pyrimidine-5-yl}-2,2-dimethyl-3,5-dioxane-6-heptenoic acid
10/19/2011	CN102219751A Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof
10/19/2011	CN102219725A Benzohetercyclic compound as well as preparation method and applications thereof
10/19/2011	CN101384577B Novel coumarin derivative having antitumor activity
10/19/2011	CN101180296B Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
10/18/2011	US8039636 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/18/2011	US8039622 Melanocortin receptor agonists
10/18/2011	US8039489 Guanidine-containing compounds useful as muscarinic receptor antagonists
10/18/2011	US8039467 Compounds for the treatment of inflammatory disorders
10/18/2011	US8039125 Compound comprising phenyl pyridine units
10/18/2011	CA2598294C Pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative
10/18/2011	CA2494049C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2398018C Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/13/2011	WO2011127388A2 Inverse agonists and neutral antagonists for the tsh receptor
10/13/2011	WO2011127290A2 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
10/13/2011	WO2011127051A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto
10/13/2011	WO2011126903A2 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	WO2011125317A1 Triazole derivative and pest control agent
10/13/2011	WO2011124930A1 P38 map kinase inhibitors
10/13/2011	WO2011123937A1 Kinase inhibitors and method of treating cancer with same
10/13/2011	WO2011086412A3 Imidazolone-chalcone derivatives as potential anticancer agent and process for the preparation thereof
10/13/2011	WO2011083495A3 Process for the preparation of dihydroxy protected derivatives and novel intermediate compounds
10/13/2011	WO2010105772A8 Novel method for producing enaminocarbonyl compounds
10/13/2011	WO2010069502A8 Tetrazole substituted anthranilic acid amides as pesticides
10/13/2011	US20110251388 1-heterodiene derivative and harmful organism control agent
10/13/2011	US20110251379 Compounds useful for treating neurodegenerative disorders
10/13/2011	US20110251253 Solid forms of (r)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide
10/13/2011	US20110251238 Ppar agonist compositions and methods of use
10/13/2011	US20110251207 Biaryl-spiroaminooxazoline analogues as alpha 2c adrenergic receptor modulators
10/13/2011	US20110251204 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251180 Pharmaceutical agent comprising quinolone compound
10/13/2011	US20110251171 Heterocyclic compounds and methods of use
10/13/2011	US20110251168 3-aminopyrrolidine derivatives as modulators of chemokine receptors
10/13/2011	US20110250699 Fluorescent Dye Compounds, Conjugates and Uses Thereof
10/13/2011	US20110250145 Bioluminescence imaging of myeloperoxidase activity in vivo, methods, compositions and apparatuses therefor
10/13/2011	CA2829790A1 Multisubstituted aromatic compounds as inhibitors of thrombin
10/13/2011	CA2795804A1 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof
10/13/2011	CA2795748A1 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 694